FI963674A - Recombinant DNA adenoviruses encoding brain neurotrophic factor (BDNF) - Google Patents

Recombinant DNA adenoviruses encoding brain neurotrophic factor (BDNF) Download PDF

Info

Publication number
FI963674A
FI963674A FI963674A FI963674A FI963674A FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A
Authority
FI
Finland
Prior art keywords
bdnf
recombinant dna
neurotrophic factor
adenoviruses encoding
brain neurotrophic
Prior art date
Application number
FI963674A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI963674A0 (en
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI963674A publication Critical patent/FI963674A/en
Publication of FI963674A0 publication Critical patent/FI963674A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Plant Pathology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI963674A 1994-03-18 1996-09-17 Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF) FI963674A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403191A FR2717496B1 (en) 1994-03-18 1994-03-18 Recombinant viruses, preparation and use in gene therapy.
PCT/FR1995/000250 WO1995025804A1 (en) 1994-03-18 1995-03-02 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)

Publications (2)

Publication Number Publication Date
FI963674A true FI963674A (en) 1996-09-17
FI963674A0 FI963674A0 (en) 1996-09-17

Family

ID=9461190

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963674A FI963674A0 (en) 1994-03-18 1996-09-17 Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF)

Country Status (12)

Country Link
EP (1) EP0750676A1 (en)
JP (1) JPH09510358A (en)
KR (1) KR970701784A (en)
AU (1) AU703793B2 (en)
CA (1) CA2184200A1 (en)
FI (1) FI963674A0 (en)
FR (1) FR2717496B1 (en)
IL (1) IL112992A0 (en)
MX (1) MX9603490A (en)
NO (1) NO963559L (en)
WO (1) WO1995025804A1 (en)
ZA (1) ZA952244B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830857A (en) * 1995-07-14 1998-11-03 Amgen Inc. Method of treating epilepsy
FR2753379B1 (en) * 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS
ES2322332T3 (en) * 2000-05-05 2009-06-19 The Research Foundation Of The City University Of New York COMPOSITIONS TO STIMULATE THE REGENERATION OF THE NERVOUS SYSTEM AND REPAIR THROUGH THE REGULATION OF THE SYNTHESIS OF POLYAMIDS AND ARGINASE 1.
EP3755380A4 (en) * 2018-02-20 2021-12-08 Carmel-Haifa University Economic Corporation Ltd. Compositions and methods for delivery and expression of small inhibitory peptides and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT70275A (en) * 1991-07-10 1995-09-28 Regeneron Pharma Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules
WO1993008828A1 (en) * 1991-11-08 1993-05-13 Syntex-Synergen Neuroscience Joint Venture Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
FR2688514A1 (en) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
WO1994003199A1 (en) * 1992-08-04 1994-02-17 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
FR2704234B1 (en) * 1993-04-22 1995-07-21 Centre Nat Rech Scient RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY.

Also Published As

Publication number Publication date
IL112992A0 (en) 1995-06-29
CA2184200A1 (en) 1995-09-28
FR2717496B1 (en) 1996-04-12
KR970701784A (en) 1997-04-12
AU1896295A (en) 1995-10-09
JPH09510358A (en) 1997-10-21
NO963559L (en) 1996-08-26
WO1995025804A1 (en) 1995-09-28
FR2717496A1 (en) 1995-09-22
EP0750676A1 (en) 1997-01-02
AU703793B2 (en) 1999-04-01
ZA952244B (en) 1996-01-16
FI963674A0 (en) 1996-09-17
MX9603490A (en) 1997-03-29

Similar Documents

Publication Publication Date Title
AU2319497A (en) Helper-free, totally defective adenovirus for gene therapy
EP0797581A4 (en) Novel protein tyrosine kinase, jak3
DE69729081T2 (en) TRANSFER CONTROLLED DC-LOW CODING SCHEME
DK0807419T3 (en) Compact, external fixation means
DE69739796D1 (en) Color image processing between separations using error diffusion
NO970174D0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones
AU5481686A (en) Foldable framework for bed, stretcher or bridge
ZA9710288B (en) Novel genes encoding telomerase proteins.
IL126403A0 (en) Al-2 neurotrophic factor
DE59504180D1 (en) Ion permeable, infrared reflecting electrode
FI963674A (en) Recombinant DNA adenoviruses encoding brain neurotrophic factor (BDNF)
EP0763046A4 (en) Dna encoding gls1
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
HUP0001969A3 (en) The neurotrophic factor nnt-1
NO901434L (en) NEUROTROPHIC PEPTIDES.
EP1044216A4 (en) DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1
EP0958304A4 (en) Nucleotide sequence encoding the cd33-like protein
DE9415089U1 (en) Central heating system
DE69738977D1 (en) NEW FUSION PROTEIN, DAFUER ENCODING GENE, REBATE APPLICATION
NO20010088D0 (en) Neurotrophic factors
IL140030A0 (en) Polypeptides dna molecules encoding them
ZA959051B (en) Recombinant dna
ITPD940057A0 (en) PERFECTED HEATING INSULATING GLASS.
DK52893D0 (en) POLYPEPTIDES, DNA CODING FOR THE POLYPEPTIDES, AND USES THEREOF
SE9401043D0 (en) Ports (Pools), purification, circ., Heating

Legal Events

Date Code Title Description
MA Patent expired